Gentelon is a patented combination of three natural products, for depressed individuals who desire or require an alternative to synthetic antidepressants.
Stage
Product In Development
Industry
Biotechnology
Location
Boston, MA, US
Currency
USD
Founded
2011
Employees
2
Company Summary
Alexander Vuckovic, M.D. LLC is developing a medical food, called Gentelon, for the treatment of major depression. In contrast to existing synthetic antidepressants, Gentelon is made from three natural substances that have already been shown to posses antidepressant activity. Gentelon has strong IP from a patent that was just recently issued. The medical need for alternative antidepressants represents a very large commercial opportunity.